{"schema_version":"secwatch.filing_event.v1","accession":"0000939767-25-000115","form_type":"8-K","ticker":"EXEL","cik":"0000939767","company_name":"EXELIXIS, INC.","filed_at":"2025-08-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.743655+00:00","generated_at":"2026-05-17T09:22:10.467366+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Exelixis appoints Dana Aftab as EVP R&D; Amy Peterson departs as CMO","bullets":["Dana Aftab, Ph.D., promoted to EVP of R&D effective August 29, 2025; previously EVP Discovery & CSO.","Amy C. Peterson, M.D., concluded service as EVP Product Development and CMO on same date.","Dr. Peterson eligible for severance under Exelixis's Change in Control and Severance Benefit Plan.","No other officer changes disclosed; Dr. Aftab's compensation terms unchanged from prior proxy filing."],"urls":{"canonical":"https://secwatch.observer/filing/0000939767-25-000115","json":"https://secwatch.observer/filing/0000939767-25-000115.json","markdown":"https://secwatch.observer/filing/0000939767-25-000115.md","text":"https://secwatch.observer/filing/0000939767-25-000115.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000115/0000939767-25-000115-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/939767/000093976725000115/exel-20250829.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:22:10.467366+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}